{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:14:31Z","timestamp":1773922471106,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.revmed.2013.08.013","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T19:01:10Z","timestamp":1381172470000},"page":"421-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["La myasth\u00e9nie du c\u00f4t\u00e9 de l\u2019interniste"],"prefix":"10.1016","volume":"35","author":[{"given":"B.","family":"Eymard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2013.08.013_bib0005","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","article-title":"Increasing incidence of late-onset anti-AChR antibody- seropositive myasthenia gravis","volume":"65","author":"Somnier","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.08.013_bib0010","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1749-6632.1981.tb33764.x","article-title":"The natural course of myasthenia gravis and effect of therapeutic measures","volume":"377","author":"Grob","year":"1981","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2013.08.013_bib0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neurol.2008.11.020","article-title":"Anticorps dans la myasth\u00e9nie","volume":"165","author":"Eymard","year":"2009","journal-title":"R Neurol"},{"key":"10.1016\/j.revmed.2013.08.013_bib0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/WNL.38.1.138","article-title":"Neonatal myasthenia gravis: a new clinical and immunological appraisal on 30\u00a0cases","volume":"38","author":"Morel","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.08.013_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(95)92652-6","article-title":"Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen","volume":"346","author":"Vincent","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2013.08.013_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.revmed.2013.08.013_bib0035","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative","volume":"60","author":"Sanders","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.08.013_bib0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2013.08.013_bib0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4\u00a0autoantibodies in AChR- and antiMuSK-antibody negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2013.08.013_bib0050","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archneur.58.6.885","article-title":"Anti-titin antibodies in myasthenia gravis. Tight association with thymoma and heterogoneity of non-thymoma patients","volume":"58","author":"Yamamoto","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2013.08.013_bib0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2013.08.013_bib0060","first-page":"444","article-title":"La myasth\u00e9nie, mod\u00e8le de maladie par auto-anticorps","volume":"138","author":"Goulon","year":"1987","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.revmed.2013.08.013_bib0065","series-title":"Examen \u00e9lectromyographique. S\u00e9m\u00e9iologie \u00e9lectrophysiologique des nerfs et des muscles","author":"Fournier","year":"2008"},{"key":"10.1016\/j.revmed.2013.08.013_bib0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0035-3787(04)70888-7","article-title":"Lambert-Eaton myasthenic syndrome. Review","volume":"160","author":"Newsom-Davis","year":"2004","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2013.08.013_bib0075","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/01.WNL.0000037485.56217.5F","article-title":"Seronegative Lambert-Eaton myasthenic syndrome: study of 110\u00a0Japanese patients","volume":"59","author":"Nakao","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.08.013_bib0080","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","article-title":"SOX1\u00a0antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"18","author":"Sabater","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.08.013_bib0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nmd.2011.10.009","article-title":"Current status of the congenital myasthenic syndromes","volume":"22","author":"Engel","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.revmed.2013.08.013_bib0090","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0035-3787(13)70060-2","article-title":"Syndromes myasth\u00e9niques cong\u00e9nitaux\u00a0: difficult\u00e9s diagnostiques, \u00e9volution et pronostic, th\u00e9rapeutique. L\u2019exp\u00e9rience du r\u00e9seau national \u00ab\u00a0Syndromes myasth\u00e9niques cong\u00e9nitaux\u00a0\u00bb","volume":"169","author":"Eymard","year":"2013","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2013.08.013_bib0095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1212\/WNL.39.4.561","article-title":"End-plate dysfunction in acute organophosphate intoxication","volume":"39","author":"Besser","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.08.013_bib0100","first-page":"114","article-title":"Myasthenia associated with D-Penicillamine therapy in rheumatoid arthritis","volume":"70","author":"Bucknall","year":"1977","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.revmed.2013.08.013_bib0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/art.1780230414","article-title":"Penicillamine-induced myasthenia gravis myasthenia gravis in progressive systemic sclerosis","volume":"23","author":"Torres","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.08.013_bib0110","first-page":"2236","article-title":"Myasth\u00e9nie induite par la D-p\u00e9nicillamine. \u00c9tude des corr\u00e9lations immunocliniques dans 23\u00a0cas","volume":"14","author":"D\u2019Anglegean","year":"1985","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2013.08.013_bib0115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2012.05.011","article-title":"Anti-MusK and anti-RACh positive myasthenia gravis induced by D-penicillamine","volume":"250","author":"Poulas","year":"2012","journal-title":"J Neuroimmunol"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.revmed.2013.08.013_bib0120","first-page":"240","article-title":"Chronic D-Penicillamine administration creates a new antigenic determinant reactive in D-Pecillamine myasthenia gravis","volume":"34","author":"Penn","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.08.013_bib0125","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archneur.1989.00520400124033","article-title":"Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction","volume":"46","author":"Robberecht","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2013.08.013_bib0130","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1055\/s-2008-1070589","article-title":"Myasthenic syndrome during chloroquine treatment","volume":"106","author":"Shumm","year":"1981","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.revmed.2013.08.013_bib0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/17843286.1991.11718197","article-title":"Persisting chloroquine-induced myasthenia","volume":"46","author":"De Bleecker","year":"1991","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.revmed.2013.08.013_bib0140","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00415-011-6335-z","article-title":"The association of systemic lupus erythematosus and myasthenia gravis: a series of 17\u00a0cases, with a special focus on hydroxychloroquine use and a review of the literature","volume":"25","author":"Jallouli","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2013.08.013_bib0145","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1212\/WNL.49.6.1747-a","article-title":"Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment","volume":"49","author":"Blake","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.08.013_bib0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0022-510X(99)00082-9","article-title":"Exacerbation of myasthenia gravis in a patient after interferon-beta treatment for chronic active hepatitis C","volume":"165","author":"Harada","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.revmed.2013.08.013_bib0155","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1196\/annals.1405.028","article-title":"Etanercept treatment in myasthenia gravis","volume":"1132","author":"Rowin","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2013.08.013_bib0160","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/mus.21280","article-title":"Myasthenia gravis associated with etanercept therapy","volume":"39","author":"Fee","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2013.08.013_bib0165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/mus.21748","article-title":"Comment on myasthenia gravis associated with TNF-alpha receptor blockers: a multifaceted issue","volume":"42","author":"Galassi","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2013.08.013_bib0170","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jnnp.2008.158279","article-title":"Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases","volume":"80","author":"Rahman","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2013.08.013_bib0175","first-page":"299","article-title":"L\u2019association polymyosite, myasth\u00e9nie thymome. Un cas et revue de la litt\u00e9rature","volume":"135","author":"Weiller","year":"1984","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.revmed.2013.08.013_bib0180","first-page":"370","article-title":"Concomitant polymyositis and myasthenia gravis reveal malignant thymoma. A case report and review of the literature","volume":"150","author":"Raschilas","year":"1999","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.revmed.2013.08.013_bib0185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.1966.tb45463.x","article-title":"Muscle lesions in myasthenia gravis","volume":"135","author":"Fenichel","year":"1966","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2013.08.013_bib0190","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.41.9.1497","article-title":"Inflammation at the neuromuscular junction in myasthenia gravis","volume":"41","author":"Maselli","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.08.013_bib0195","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.nmd.2006.07.002","article-title":"Isaacs\u2019 syndrome associated with myasthenia gravis, showing remission after cytoreductive surgery of pleural recurrence of thymoma","volume":"16","author":"Fukushima","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.revmed.2013.08.013_bib0200","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0035-3787(04)71010-3","article-title":"Neuromyotonia","volume":"160","author":"Newsom-Davis","year":"2004","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2013.08.013_bib0205","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1254.022","article-title":"Autoimmune disorders of neuronal potassium channels","volume":"998","author":"Newsom-Davis","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2013.08.013_bib0210","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/jnnp.73.3.344-a","article-title":"Neuromyotonia and myasthenia gravis without thymoma","volume":"73","author":"Van Parijs","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2013.08.013_bib0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neurol.2009.01.005","article-title":"Therapeutic strategy in myasthenia gravis","volume":"165","author":"Tranchant","year":"2009","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2013.08.013_bib0220","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.neurol.2009.09.006","article-title":"Traitement de la myasth\u00e9nie auto-immune","volume":"166","author":"Penisson-Besnier","year":"2010","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2013.08.013_bib0225","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia","volume":"78","author":"D\u00edaz-Manera","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.08.013_bib0230","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.34468","article-title":"Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies","volume":"64","author":"Molloy","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.08.013_bib0235","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1212\/WNL.0b013e31827b907b","article-title":"Complete stable remission and antibody specificity in myasthenia gravis","volume":"80","author":"Biaggi","year":"2013","journal-title":"Neurology"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886631300636X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886631300636X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:33:09Z","timestamp":1759336389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S024886631300636X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S024886631300636X"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2013.08.013","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La myasth\u00e9nie du c\u00f4t\u00e9 de l\u2019interniste","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2013.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}